Neurology: Volume 96, Number 13, March 30, 2021 Exam #1 - Microbleeds, Cerebral Hemorrhage, and Functional Outcome After Endovascular Thrombectomy

About this course

  • Released: 03/30/2021
  • Expires: 03/30/2024

MICROBLEEDS, CEREBRAL HEMORRHAGE, AND FUNCTIONAL OUTCOME AFTER ENDOVASCULAR THROMBECTOMY

LEARNING OBJECTIVES:

Upon completion of the article by Derraz et al, the participant should be able to:
  • Identify patient-specific characteristics that were observed more commonly among patients with acute ischemic stroke with cerebral microbleeds (CMBs) on MRis done prior to endovascular therapy (EVT) in this study
  • Describe how, after controlling for other factors, the presence of CMBs on pretreatment MRI impacted clinical outcomes at 3 months in patients undergoing EVT for acute ischemic stroke in this study
  • Discuss how the presence, location, and presumed pathogenesis of CMBs impacted the risk of symptomatic brain hemorrhage in patients with acute ischemic stroke undergoing EVT in this study

CORE COMPETENCIES:

The article by Derraz et al covers the following core competency:
  • Medical Knowledge

AUTHOR DISCLOSURES:

Refer to Information and Author section available in the Tool Bar for each article.

THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES

ACCREDITATION STATEMENT

The American Academy of Neurology Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

MISSION STATEMENT/PROGRAM OBJECTIVES

After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.

PARTICIPANTS

This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.

AMA CREDIT DESIGNATION STATEMENT

The American Academy of Neurology Institute designates this journal-based-CME activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURES

James WM Owens Jr. MD, PhD receives royalties from UpToDate, Waltham, MA; grant support from NIH (PI, K08NS054882); and a stipend in his editorial capacity for Neurology. Adam Kelly, MD, has served as a guest editor of Continuum (April 2014) and receives a stipend in his editorial capacity for Neurology.

COMMERCIAL SUPPORT

This CME program receives no commercial support.

ACCME